A071701-Genomically-Guided Treatment Trial in Brain Metastases

About this Study

The purpose of the study is to test the good and bad effects of using the study drugs Abemaciclib, GDC-0084 and Entrectinib versus the usual approach  for metastatic cancer. 

Sponsor Protocol ID:A071701
IRB Number:2019-0259
Actively Enrolling
Interventional
Phase 2
June 17, 2020
Eligibility Criteria
18 years old
Both Male and Female
Yes
No
No
Categories Click category to view its trials.
Cancer
Neurosciences
Participating Locations
Cancer Center and Research Institute - UMMC
University Hospital - UMMC
Contact Information
Contact Name: Bridgett Sessions
Phone Number: 601-984-1962
Email: brellis@umc.edu
Principal Investigator:Shaikh, Nawal I, M.D.
How to participate in our Clinical Trials